Rachel W. Humphrey
2016
In 2016, Rachel W. Humphrey earned a total compensation of $1.3M as Chief Medical Officer at CytomX Therapeutics, a 74% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $193,550 |
|---|---|
| Option Awards | $639,412 |
| Salary | $395,000 |
| Other | $34,072 |
| Total | $1,262,034 |
Humphrey received $639.4K in option awards, accounting for 51% of the total pay in 2016.
Humphrey also received $193.6K in non-equity incentive plan, $395K in salary and $34.1K in other compensation.
Rankings
In 2016, Rachel W. Humphrey's compensation ranked 7,128th out of 14,075 executives tracked by ExecPay. In other words, Humphrey earned more than 49.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,128 out of 14,075 | 49th |
Division Manufacturing | 2,684 out of 5,489 | 51st |
Major group Chemicals And Allied Products | 875 out of 1,895 | 54th |
Industry group Drugs | 675 out of 1,538 | 56th |
Industry Pharmaceutical Preparations | 536 out of 1,176 | 54th |
Source: SEC filing on May 9, 2017.
Humphrey's colleagues
We found three more compensation records of executives who worked with Rachel W. Humphrey at CytomX Therapeutics in 2016.